Akido

Akido raises $60M Series B to expand ScopeAI for improved healthcare access

19th May, 2025

Chris Davis

Writer

Akido raises $60M Series B to expand ScopeAI for improved healthcare access

What does Akido do?

Akido is an AI-driven healthcare company that bridges artificial intelligence with empathetic care delivery. The company leverages advanced technology to enhance clinical experiences and empower both providers and patients.

How much did they raise?

The company raised $60M in a Series B round led by Oak HC/FT, with participation from Greco, SNR, Y Combinator, Future Communities Capital, Jeff Dean, and the Comprehensive Blood and Cancer Center.

What are their plans for the money?

With the new funds, Akido plans to expand the reach of its ScopeAI system, aiming to increase clinical capacity and improve access to healthcare for underserved communities. This strategic move is expected to further innovate the delivery of care.

What have they achieved so far?

Since its founding in 2015, Akido has made significant strides, including the launch of Akido Care in 2022. Today, its network spans nearly 100 clinics offering primary and specialty care, demonstrating progress towards its mission.

Key Contacts

Prashant Samant
CEO

Company Links

Looking for startup leads?

Every week we source, enrich and send you leads of decision makers from recently funded startups. Sent to you every Monday.

Learn more

Newsletter

Get a daily roundup of recently funded startups.

Recently raised

The latest funding rounds from our newsroom

© JustRaised 2025. All rights reserved.